The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

New number of shares and votes in Cavotec SA

31 Jan 2019 17:00



New number of shares and votes in Cavotec SA

Cavotec SA ("Cavotec") has, in accordance with previously announced information, issued new shares in a rights issue which has increased the total number of outstanding shares and votes in Cavotec to 94,243,200.

Prior to the rights issue, the total number of outstanding shares and votes in Cavotec was 78,536,000. Through the rights issue the number of shares in Cavotec increased by 15,707,200, corresponding to 15,707,200 votes. Today, the last trading day of the month, the total number of shares and votes in Cavotec is 94,243,200.

ENDS

For further details please contact:

Johan HähnelInvestor Relations ManagerTelephone: +46 70 605 63 34 - Email: investor@cavotec.com

This is information that Cavotec SA is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication on 31 January, 2019 at 18:00 CET.

About CavotecCavotec is a leading engineering group that designs and manufactures automated connection and electrification systems for ports, airports and industrial applications worldwide. Cavotec’s innovative technologies ensure safe, efficient and sustainable operations. To find out more about Cavotec, visit our website at cavotec.com.


Attachment




Press Release 31 January



Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.